For Orexo, as an innovative company, a strong patent portfolio that covers all existing products and pipeline projects is central for the business. The patent strategy involves having the proper protection in place on the relevant markets for any given product. Product specific patents are important assets, whether the company chooses to sell a product via a commercial partner, or bring it to the market by Orexo’s own commercial team. As a pharmaceutical company present on the US market, having enforceable patents listed in FDA’s ‘Orange Book’ for the company’s drug products is a very important part of the strategy.

Orexo has an in-house IP department that work in close collaboration with innovators and the development team, as well as with external counsel, to ascertain that all aspects of the innovative process are covered, laying the foundation for the patents in the portfolio. Orexo’s global experience of patent enforcement is an invaluable asset in shaping the patent strategy.